Machine Learning Scientist/Sr. Scientist - Drug Target Discovery
Systimmune
About this role
SystImmune, a clinical-stage biopharmaceutical company focusing on cancer treatments, is expanding its AI and computational discovery team. The company develops biologics like bispecific antibodies and ADCs, and seeks a Machine Learning Scientist to advance drug discovery and therapeutic design through AI applications, collaborating across scientific disciplines.
Skills
Qualifications
About Systimmune
systimmune.comSystImmune is a Redmond, WA–based biopharmaceutical company developing bi‑specific and multi‑specific antibodies and antibody‑drug conjugates (ADCs) to treat cancer. Its mission is to create biologics that both directly attack tumors and activate the immune system to enhance anti‑tumor responses, using proprietary protein‑engineering and antibody‑discovery platforms. A multidisciplinary team across the U.S. and China focuses on rapid, cost‑efficient clinical development. SystImmune is a member of the Biokin Pharmaceutical group and partners with Bristol Myers Squibb and OrbiMed, and it is seeking additional collaborators to develop and commercialize its therapies worldwide.
About Systimmune
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Systimmune.
Salary
$100k – $180k
per year
More jobs at Systimmune
Similar Jobs
Process Development Senior Scientist - Pivotal Biologics Drug Substance Technology
Amgen
Senior Scientist, Biologics Design and Display, Discovery Biologics
MSD
Senior Director, Biologics Analytical Research & Development
AbbVie
Senior Scientist (Discovery Biology)
Cancer Research UK
Senior Scientist - Display Technologies (Antibody Discovery)
Cancer Research UK
Associate Principal Scientist, Discovery Oncology
MSD